Rules concerning screening of safety and efficacy on drugs to be eased

The Korea Food and Drug Administration (KFDA) said it would re-draft the current rules concerning the screening of safety and efficacy on drugs, in line with the introduction of simplified protocol system for drugs, etc. in clinical phases, being separated from the screening of safety and efficacy. The KFDA further noted that:

- In the case of amino acid infusions whose local clinical exper...